ArticleProceedings of the National Academy of Sciences of the United States of America2024

Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor-ligand signaling complex.

Jialiu Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.